Novo Nordisk’s high-dose Wegovy approved in the U.S. | STAT
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A higher dose version of the weight loss drug Wegovy has been approved in the US. The approval is seen as a boost for Novo Nordisk, the drug's manufacturer. The higher dose of Wegovy has been reported to achieve significant weight loss in some patients, with one source noting nearly 28% weight loss in early responders.
Full coverage
1
CNBC·Mar 192
Stocktwits·4d ago3
WSJ·Mar 194
Clinical Trials Arena·May 135
Fierce Pharma·Mar 196
PR Newswire·Apr 77
Bloomberg.com·Mar 198
Yahoo Finance·Mar 20